TheraRadar
← Back
Data updated: Jun 28, 2026

PVT FORM

Pharma

PVT FORM is a pharmaceutical company focused on Gastroenterology, Cardiovascular, Infectious Disease.

1975
Since
25
Drugs
-
Trials
0
New Drugs (2yr)

PVT FORM's Key Drugs

PVT FORM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

PVT FORM's Recent FDA Approvals

New NDA/BLA approvals for PVT FORM over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

PVT FORM's Therapeutic Areas

PVT FORM's approved drugs and pipeline span 5 therapeutic areas, led by Gastroenterology and Cardiovascular. Weighted by commercial stage — approved drugs count most, then late-stage trials.

Gastroenterology 33%
2 drugs
Cardiovascular 17%
1 drugs
Infectious Disease 17%
1 drugs
Respiratory 17%
1 drugs
Dermatology 17%
1 drugs

PVT FORM Pipeline Snapshot

Active clinical trials for PVT FORM across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • Top drug revenue breakdown
  • Drug-level revenue analysis

Trial Catalysts

  • Gastroenterology pipeline focus
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling